
    
      The primary objective of this study is to determine the impact of early versus delayed
      initiation of treatment on the long-term physical status of patients with relapsing forms of
      MS measured by the self-reported EDSS.

      Primary endpoints for this study were as follows:

        1. Changes in EDSS score from baseline for original AvonexÂ® pivotal trial

        2. Percentage of patients with EDSS scores less than or equal to 4

        3. Percentage of patients with EDSS scores less than or equal to 6

        4. Percentage of patients with EDSS scores less than or equal to 7

      Secondary endpoints were:

        1. Percentage of patients alive

        2. Percentage of patients living independently

        3. SF 36 Quality of Life status

        4. Self-reported VAS of independence with self-care
    
  